Concepedia

Gary Landucci

GL

Statistics

Publications

47

Citations

5.2K

H-Index

29

Active since

1971

Affiliations

University of California, Irvine(Current)

Scripps Research Institute

Duke Medical Center

Ragon Institute of MGH, MIT and Harvard

University of California, Irvine Medical Center

Gary Landucci is an author at University of California, Irvine specializing in infectious diseases, immunology, and life sciences.

Publications per year

1971–2024

47

Publications

47

Fc receptor but not complement binding is important in antibody protection against HIV

Ann J. Hessell, Lars Hangartner, Meredith Hunter et al. · Nature · 2007 · 899 citations

, , +16

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu et al. · Journal of Virology · 2008 · 624 citations · Full text

, , +12

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

Ann J. Hessell, Eva G. Rakasz, Pascal Poignard et al. · PLoS Pathogens · 2009 · 495 citations · Full text

, , +17

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

Jinyan Liu, Kara L. O’Brien, Diana M. Lynch et al. · Nature · 2008 · 448 citations · Full text

, , +17

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIV <sub>Ba-L</sub>

Ann J. Hessell, Eva G. Rakasz, David M. Tehrani et al. · Journal of Virology · 2009 · 318 citations · Full text

, , +17

1–5 of 47